Skip to main content
. 2021 Sep 29;8:725852. doi: 10.3389/fcvm.2021.725852

Table 3.

Echocardiographic characteristics of elite endurance and strength athletes and non-elite controls.

Participants attending a 3-KM run test
(N = 1,388)
Participants attending a 2-min push-up test
(N = 577)
Echocardiographic characteristics Elite endurance athletes (≤780 s)
(N = 233)
Controls (>780 s) (N = 1,155) P-value Elite strength athletes (≥54 times) (N = 78) Controls
(<54 times)
(N = 499)
P-value
Aortic valve open (mm), PLAX 19.93 ± 1.98 20.03 ± 1.91 0.57* 20.53 ± 1.65 20.35 ± 1.86 0.61*
Aortic root dimension (mm), PALX 29.49 ± 3.23 29.68 ± 3.25 0.66* 30.13 ± 2.48 29.82 ± 2.74 0.19*
LV posterior wall (mm), PLAX* 8.44 ± 0.89 8.54 ± 0.94 0.31* 8.40 ± 0.76 8.29 ± 0.84 0.84*
LV internal dimension in diastole (mm), PLAX 50.03 ± 3.35 49.24 ± 3.42 0.003* 49.74 ± 3.19 49.07 ± 3.50 0.36*
Interventricular septum, (mm), PLAX 8.61 ± 0.95 8.74 ± 1.02 0.44* 8.53 ± 0.80 8.49 ± 0.89 0.45*
RV wall thickness (mm), PLAX* 4.72 ± 0.55 4.66 ± 0.62 0.98* 4.60 ± 0.67 4.70 ± 0.58 0.49*
RV outflow tract dimension in diastole (mm), PLAX 25.94 ± 3.84 27.19 ± 12.49 0.82* 26.47 ± 3.82 26.33 ± 3.96 0.45*
Left atrial dimension (mm), PLAX 32.55 ± 4.00 32.95 ± 3.93 0.21* 33.09 ± 3.40 32.83 ± 3.95 0.11*
LV mass (gm) 152.53 ± 28.43 151.05 ± 29.83 0.16 148.98 ± 23.54 144.45 ± 27.18 0.16
LV mass index (gm/m2) 84.44 ± 13.56 80.52 ± 12.94 <0.001 81.76 ± 11.36 77.51 ± 12.05 0.004
LV hypertrophy 11 [4.7] 24 [2.1] 0.01 1 [1.3] 5 [1.0] 0.82
RV hypertrophy 20 [8.6] 84 [7.3] 0.48 2 [2.6] 26 [5.2] 0.31
LV ejection fraction (%), PLAX 61.79 ± 5.03 61.97 ± 5.06 0.78 62.86 ± 5.36 62.43 ± 5.32 0.51
Tricuspid valve prolapse, PSAX 34 [20.4] 206 [26.6] 0.09 13 [41.9] 94 [51.1] 0.34
Aortic regurgitation ≥ mild grade 3 [1.3] 13 [1.1] 0.83 1 [1.3] 3 [0.6] 0.50
Mitral regurgitation ≥ mild grade 190 [81.5] 890 [77.1] 0.13 69 [88.5] 429 [86.0] 0.55
Pulmonary regurgitation ≥ mild grade 162 [69.5] 763 [66.1] 0.30 61 [78.2] 354 [70.9] 0.18
Tricuspid regurgitation ≥ mild grade 196 [84.1] 928 [80.3] 0.18 73 [93.6] 462 [92.6] 0.75
RV systolic pressure (mmHg) 27.68 ± 4.35 27.19 ± 4.36 0.27 29.60 ± 4.35 27.83 ± 3.71 <0.001
Mitral inflow power Doppler E-wave (m/s) 87.00 ± 14.13 86.21 ± 14.87 0.45 90.07 ± 13.63 87.41 ± 14.59 0.13
Mitral inflow power Doppler A-wave (m/s) 46.44 ± 9.59 48.69 ± 9.81 0.001 48.81 ± 9.42 49.31 ± 9.88 0.67
E/A ratio 1.94 ± 0.46 1.83 ± 0.46 0.001 1.91 ± 0.48 1.84 ± 0.47 0.20
Mitral lateral annulus tissue Doppler E' (cm/s) 17.33 ± 3.83 17.04 ± 3.75 0.29 19.30 ± 4.06 18.18 ± 4.05 0.02
Mitral lateral annulus tissue Doppler A' (cm/s) 7.77 ± 2.16 8.30 ± 3.69 0.03 8.51 ± 1.82 9.31 ± 4.95 0.16
E'/A' ratio 2.37 ± 0.73 2.22 ± 0.76 0.007 2.36 ± 0.70 2.11 ± 0.71 0.004

Continuous variables are expressed as mean ± SD (standard deviation), and categorical variables as N [%].

LV, left ventricle; RV, right ventricl; PLAX, echocardiographic parasternal long axis view; PSAX, echocardiographic parasternal short axis view.

*

Analysis of covariance (ANCOVA) with adjustment for body surface area.